Shao Qi-xiang
Jiangsu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shao Qi-xiang.
Rheumatology International | 2012
Wang Kaiwen; Su Zhaoliang; Zhao Yinxia; Sandoghchian Shotorbani Siamak; Jiao Zhi-jun; Xue Yuan; Yang Heng; Zheng Dong; Liu Yanfang; Shen Pei; Wang Shengjun; Shao Qi-xiang; Huang Xin-xiang; Lu Liwei; Xu Huaxi
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease. It is a systemic inflammatory disease, characterized by chronic, symmetrical, multi-articular synovial arthritis. IL-25 (IL-17E) is a member of the recently emerged cytokine family (IL-17s), which is expressed in Th2 cells and bone marrow-derived mast cells. Unlike the other members of this family, IL-25 is capable of inducing Th2-associated cytokines (IL-4, IL-5, and IL-13) and also promotes the release of some pro-immune factors (IL-6 and IL-8). IL-25 is also a pleiotropic factor, which constitutes a tissue-specific pathological injury and chronic inflammation. In this study, we used chicken collagen II-induced experimental arthritis (CIA) model in DBA/1 mice to investigate the relationship between IL-25 and other inflammatory factors, revealing the possible mechanism in CIA. Our results showed that the expression level of IL-25 was enhanced in the late stage of CIA, and IL-17 was increased in the early stage of the disease. It is well known that IL-17 has a crucial role in the development of RA pathogenesis, and IL-25 plays a significant role in humoral immune. For reasons given above, we suggested that the IL-25 inhibited IL-17 expression to some extent, while enhancing the production of IL-4. It was confirmed that IL-25 not only regulated the cellular immune, but also involved the humoral immune in rheumatoid arthritis.
Vaccine | 2012
Han Qingzhen; Tong Jia; Wang Shengjun; Zhao Yang; Liu Yanfang; Shen Pei; Baidoo Samuel Essien; Su Zhaoliang; Xia Sheng; Shao Qi-xiang; Sydney M. Finegold; Huaxi Xu
Corynebacterium pyruviciproducens (C. pyruviciproducens), a newly discovered Corynebacterium, is gram-positive, non-flagellate, non-spore-forming lipophilic rod. No known pathogenic components of Corynebacteria have been found in this new bacterium, such as diphtheria toxin and tuberculostearic acid. In the present study, referring to Propionibacterium acnes (P. acnes), a well-known bacterial adjuvant, the stimulation of dendritic cells by C. pyruviciproducens was analyzed through detecting the levels of cytokine-secretion, ability of cell-proliferation and expression of membrane molecules. In addition, the effect of C. pyruviciproducens in promoting antibody production in vivo was detected. Compared with P. acnes, C. pyruviciproducens more strongly enhanced cytokine secretion including inflammatory factor IL-6 and Th1-associated molecule IL-12, and more effectively induced proliferation, activation or maturation of D2SC/1 (a murine dendritic cell line) and bone marrow-derived dendritic cells (BMDC). Vaccination studies in mice using ovalbumin (OVA) as a model antigen showed that C. pyruviciproducens effectively promoted antigen-specific humoral immune response by increasing OVA-specific antibody, Th2-biased response in spleen and high IL-4/IFN-γ ratio in serum.
Archive | 2013
Zhang Miaomiao; Du Fengyi; Gong Aihua; Shao Qi-xiang; Shao Genbao; Peng Wanxin; Jin Jie; Wu Weijiang; Zhou Zhou; Yuan Jing
Archive | 2013
Du Fengyi; Zhang Miaomiao; Shao Qi-xiang; Xia Sheng; Xu Huaxi; Xu Wenrong; Qian Hui; Liu Xia
Journal of Jiangsu University | 2011
Shao Qi-xiang
Journal of Jiangsu University | 2011
Shao Qi-xiang
Immunological Journal | 2011
Shao Qi-xiang
Progress in Modern Biomedicine | 2010
Lin Xin; Xu Xun; Zong YangYong; Shao Qi-xiang
Journal of Jiangsu University | 2010
Shao Qi-xiang
Immunological Journal | 2010
Shao Qi-xiang